Sales: $27.1 Billion Headcount: 18,000 Revenues: $27,116 (flat) Net Income: $5,613 (+23%) R&D Expenses: $5,718 (+15%) Gileads full year 2023 revenue decreased 1% to $27.1 billion compared to 2022, largely driven by a reduction of $1.7 billion in Veklury sales, but offset by higher HIV and Oncology sales
The ODT is a tablet that dissolves on your tongue
As for Dr
Brando C, Fernandes N, Mesquita N, Dinis-Ribeiro M, Silva R, Lomba Viana H, et al
There are dozens of products, tools, and procedures marketed for double chin removal, but in clinical practice, only a handful reliably change the appearance of the under-chin area